hotspot -WSS

hotspot

author：comprehensive 2025-10-01 04:45:02 - browse：6

Illumina said Monday afternoon that its board of directors had approved a spin-off of its cancer test subsidiary Grail, signaling that a nearly four-year-long, $8 billion saga will finally draw to a close this month.

Shares in the newly independent Grail are expected to be distributed on June 24, Illumina said in a statement. Illumina will retain a 14.5% stake in the company, which will trade under the ticker $GRAL.

It’s the second time Illumina has spun off Grail, which initially began as a unit within the DNA sequencing giant in 2015. Illumina turned it into an independent company the following year but then agreed to reacquire it for $8 billion in September 2020.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

WSS

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Why some fertility treatments produce more boy babies

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Decentralized clinical trials need collaboration to achieve wider use

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Public health communication lessons from Covid

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

At least 13 dead in Texas as scorching temps continue

Beyond aggravation: Constipation is an American epidemic

Walensky prepares to leave CDC — and Congress — behind

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Peter Hotez and the public health issue of online harassment

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

New air purifier tech could be key to improving indoor air quality

Behind warning on Apellis’s eye drug lies a conflict of interest

Trump demands the U.S. pay no more for drugs than other countries … again

The Bio Revolution is changing business and society

hotspot

Louisiana bill approved classifying abortion pills as controlled substances

Interest rates are at a 22

Public health communication lessons from Covid

Clinicians often fail to acknowledge the pain caused by long Covid

Will biotech layoffs continue through 2023?

Louisiana bill approved classifying abortion pills as controlled substances

explore

focus

explore

focus